|
Volumn 1, Issue 3, 2007, Pages 199-204
|
Effect of recombinant human thymosin-alpha1, an immuno-modulating peptide with 28 amino acids, on the activity of cytochrome P450s.
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CYTOCHROME P450;
DRUG DERIVATIVE;
IMMUNOLOGICAL ADJUVANT;
ISOENZYME;
RECOMBINANT PROTEIN;
THYMOSIN;
THYMOSIN ALPHA1;
ANIMAL;
ARTICLE;
DOSE RESPONSE;
DRUG EFFECT;
DRUG INTERACTION;
ENZYMOLOGY;
HUMAN;
LIVER;
LIVER MICROSOME;
MALE;
METABOLISM;
ORGAN SIZE;
RAT;
SPRAGUE DAWLEY RAT;
SUBCUTANEOUS DRUG ADMINISTRATION;
ADJUVANTS, IMMUNOLOGIC;
ANIMALS;
CYTOCHROME P-450 ENZYME SYSTEM;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG INTERACTIONS;
HUMANS;
INJECTIONS, SUBCUTANEOUS;
ISOENZYMES;
LIVER;
MALE;
MICROSOMES, LIVER;
ORGAN SIZE;
RATS;
RATS, SPRAGUE-DAWLEY;
RECOMBINANT PROTEINS;
THYMOSIN;
|
EID: 65249137009
PISSN: 18723128
EISSN: None
Source Type: Journal
DOI: 10.2174/187231207781369825 Document Type: Article |
Times cited : (6)
|
References (0)
|